Research Article
Circulating MMP-12 as Potential Biomarker in Evaluating Disease Severity and Efficacy of Sublingual Immunotherapy in Allergic Rhinitis
Figure 3
Serum MMP-12 and MRGPRX2 levels in two groups 1 year post-SLIT. (a) Serum MMP-12 levels were significantly lower in the effective group than the ineffective group, and concentrations were reduced after 1 year post-SLIT (b). (c) Serum MRGPRX2 level was significantly reduced in the effective group than the ineffective group, but the concentrations were not significantly reduced 1 year post-SLIT (d). MMP-12: matrix metalloproteinase-12; MRGPRX2: mas-related G protein-coupled receptor-X2; SLIT: sublingual immunotherapy, ; NS: no significance.
(a) |
(b) |
(c) |
(d) |